Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever
- PMID: 3366868
- PMCID: PMC266426
- DOI: 10.1128/jcm.26.4.719-725.1988
Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever
Abstract
The capsular polysaccharide of Salmonella typhi and of Citrobacter freundii (Vi) is a linear homopolymer of alpha 1,4-linked N-acetylgalactosaminuronic acid, variably O-acetylated at the C-3 position. Vaccines composed of Vi confer protection against typhoid fever with an efficacy of about 70%; Vi has recently been conjugated to proteins to increase its immunogenicity and effectiveness (I.L. Acharya, R. Tapa, V.L. Gurubacharya, M.B. Shrestha, C.U. Lowe, D.D. Bryla, R. Schneerson, J.B. Robbins, T. Crampton, B. Trollfors, M. Cadoz, D. Schulz, and J. Armand, N. Engl. J. Med. 317:1101-1104, 1987; K.P. Klugman, I. Gilbertson, H.J. Kornhof, J.B. Robbins, R. Schneerson, D. Schulz, M. Cadoz, and J. Armand, Lancet ii:1165-1169, 1987; S.C. Szu, A.L. Stone, J.D. Robbins, R. Schneerson, and J.B. Robbins, J. Exp. Med. 166:1510-1524, 1987). Vi, however, cannot be measured by conventional colorimetric methods. Two optical techniques were adapted to quantitate Vi in vaccines. The first, Fourier-transformed infrared spectroscopy, was performed on salt-free, freeze-dried samples. The intensities of the absorbance peaks of Vi were proportional to the amount of Vi within the range of 0.25 to 2.0 mg. The amount of Vi was determined from integrated absorptions at the 1,235- or 1,417-cm-1 band. The second technique, spectrophotometric titration, was more sensitive than the Fourier-transformed infrared spectroscopy and could be performed on dilute solutions. The metachromatic effect of the reaction between the aromatic cationic dye acridine orange and the carboxyl groups of Vi was quantitative within +/- 2% in the range of 20 to 700 micrograms of Vi per ml. The accuracy of the titration of Vi in the vaccines was within +/- 8%. These two methods may be applicable to measure other capsular polysaccharides in vaccines.
Similar articles
-
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26. Vaccine. 2015. PMID: 25433216
-
Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi.Biologicals. 2019 Jan;57:34-45. doi: 10.1016/j.biologicals.2018.11.004. Epub 2018 Nov 27. Biologicals. 2019. PMID: 30502020
-
Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28484685 Free PMC article.
-
Vi capsular polysaccharide: Synthesis, virulence, and application.Crit Rev Microbiol. 2017 Aug;43(4):440-452. doi: 10.1080/1040841X.2016.1249335. Epub 2016 Nov 21. Crit Rev Microbiol. 2017. PMID: 27869515 Review.
-
Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.J Infect Dis. 1984 Sep;150(3):436-49. doi: 10.1093/infdis/150.3.436. J Infect Dis. 1984. PMID: 6207249 Review.
Cited by
-
Adsorption of Vi Capsular Antigen of Salmonella Typhi in Chitosan-Poly (Methacrylic Acid) Nanoparticles.Polymers (Basel). 2019 Jul 23;11(7):1226. doi: 10.3390/polym11071226. Polymers (Basel). 2019. PMID: 31340432 Free PMC article.
-
Glycoconjugate vaccines against Salmonella enterica serovars and Shigella species: existing and emerging methods for their analysis.Biophys Rev. 2021 Apr 10;13(2):221-246. doi: 10.1007/s12551-021-00791-z. eCollection 2021 Apr. Biophys Rev. 2021. PMID: 33868505 Free PMC article. Review.
-
Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.Vaccine. 2011 Jan 17;29(4):712-20. doi: 10.1016/j.vaccine.2010.11.022. Epub 2010 Nov 27. Vaccine. 2011. PMID: 21115057 Free PMC article.
-
Structure and function relations with a T-cell-activating polysaccharide antigen using circular dichroism.Glycobiology. 2007 Jan;17(1):46-55. doi: 10.1093/glycob/cwl056. Epub 2006 Sep 21. Glycobiology. 2007. PMID: 16990347 Free PMC article.
-
Characterization of the Salmonella paratyphi C Vi polysaccharide.Infect Immun. 1989 Oct;57(10):3159-64. doi: 10.1128/iai.57.10.3159-3164.1989. Infect Immun. 1989. PMID: 2506132 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous